The Illinois Senate has approved legislation that would prevent the smell of marijuana from being used as probable cause to search a vehicle or its passengers. The Senate voted 33–20 on Thursday to pass the bill, SB 125. It’s now set to be considered by the state’s House of... Read more
You’re reading a copy of this week’s edition of the New Cannabis Ventures weekly newsletter, which we have been publishing since October 2015. The newsletter includes unique insight to help our readers stay ahead of the curve as well as links to the week’s most important news. Friends, The... Read more
As we described in a previous article, the Global Cannabis Stock Index fell in February after rising to begin the year. In March, the index plunged 15.2%, leaving it down 12.5% in the first quarter of the year. This follows a record decline of 70.4% for 2022. In this exclusive article... Read more
The National Basketball Association (NBA) is reportedly removing marijuana from its list of banned substances and will no longer drug test players for it as part of a new seven-year collective bargaining agreement. The move, first reported on Saturday by Shams Charania of The Athletic and Stadium, formally codifies... Read more
A Connecticut bill to decriminalize the possession of small amounts of psilocybin mushrooms passed a legislative committee on Wednesday. The measure would make possession of up to half an ounce of psychedelic mushrooms a civil infraction, punishable by a $150 fine. Subsequent violations would carry fines of between $200... Read more
The governor of Kentucky has signed a bill to legalize marijuana, making the state the 38th in the U.S. to enact the reform. Just one day after the House approved the legislation from Sen. Stephen West (R), Gov. Andy Beshear (D) fulfilled his pledge to sign in into law... Read more
4Front Ventures Reports Fourth Quarter and Full Year 2022 Financial Results Systemwide Pro Forma Revenue of $139.4 million for FY 2022 and $35.6 million for Q4 2022, representing a 6% YoY increase for each FY 2022 Adjusted EBITDA of $27.7 million as compared to $33.9 million in FY 2021... Read more
A bipartisan group of congressional lawmakers filed a bill this week to clarify that federal “Right to Try” (RTT) laws give seriously ill patients access to Schedule I drugs, including marijuana and psychedelics like psilocybin and MDMA. While the bipartisan measure would make a technical amendment to the text... Read more
